Which of the following statements about ankylosing spondylitis (AS) are true: a) Low back pain worsens with rest and improves with movement, b) The arthritis is asymmetric and non‑erosive, c) HLA‑B27 is positive in >90% of cases, d) Kidney involvement is common, e) Antinuclear antibodies are always positive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ankylosing Spondylitis: Statement Analysis

Statement (a) is TRUE: Low back pain in AS characteristically worsens with rest and improves with movement—this is the hallmark inflammatory back pain pattern that distinguishes AS from mechanical causes. 1, 2, 3

Detailed Analysis of Each Statement

a) Low Back Pain Pattern: TRUE ✓

The inflammatory back pain in AS demonstrates a pathognomonic pattern:

  • Worsens with rest and inactivity (particularly during the second half of the night)
  • Improves with exercise and movement
  • Associated with morning stiffness

This inflammatory characteristic is fundamental to AS diagnosis and is consistently emphasized across guidelines 1, 2. The ASAS/EULAR recommendations specifically note that pain improves with activity, distinguishing it from mechanical back pain 1.

b) Arthritis Pattern: FALSE ✗

The arthritis in AS is typically symmetric and CAN be erosive, not asymmetric and non-erosive as stated. While AS primarily affects the axial skeleton (spine and sacroiliac joints), peripheral arthritis when present tends toward symmetry. The disease causes structural damage including erosions, syndesmophytes, and eventual fusion 1, 4. The guidelines explicitly discuss radiographic structural damage and erosive changes as part of disease monitoring 1.

c) HLA-B27 Positivity: FALSE ✗

HLA-B27 is positive in approximately 80-90% of AS cases, NOT >90%. While strongly associated with AS, the prevalence varies:

  • Research indicates approximately 90% association in some populations 5
  • However, HLA-B27-negative AS exists and represents a significant minority 6
  • The association is strong but not absolute 7, 8

The statement claiming ">90%" is an overestimate. More accurately, HLA-B27 is present in 80-90% of AS patients, with variation by ethnicity and population 5, 7, 6.

d) Kidney Involvement: FALSE ✗

Kidney involvement is NOT common in AS. The guidelines consistently identify extra-articular manifestations as:

  • Acute anterior uveitis (most common)
  • Inflammatory bowel disease
  • Psoriasis
  • Aortitis/carditis

Renal involvement is not listed among the characteristic extra-articular features in any of the major guidelines 1, 9, 10, 2. The ASAS core set for disease monitoring specifically mentions uveitis, conjunctivitis, and carditis—but not kidney disease 1.

e) Antinuclear Antibodies: FALSE ✗

ANAs are NOT always positive in AS—in fact, AS is classified as a seronegative spondyloarthropathy. The evidence shows:

  • ANAs found in only 19.1% of AS patients in one study 11
  • AS is characterized by the absence of rheumatoid factor and typically negative autoantibodies
  • The term "seronegative spondyloarthritis" specifically denotes the lack of typical autoantibodies 5, 4

The frequent co-testing of HLA-B27 with ANA and rheumatoid factor (69.3% of cases) 12 represents inappropriate testing patterns, not disease characteristics.

Clinical Pitfalls to Avoid

  • Don't dismiss AS based on negative HLA-B27: 10-20% of AS patients are HLA-B27 negative 6
  • Don't confuse AS with rheumatoid arthritis: AS is seronegative; routine ANA/RF testing is not indicated 12
  • Don't overlook the characteristic pain pattern: Improvement with exercise is key to diagnosis 2, 3
  • Don't expect renal involvement: Focus on uveitis, IBD, and cardiac manifestations instead 1, 2

CORRECT ANSWER: Only statement (a) is true.

References

Research

Ankylosing spondylitis. An optimistic outlook.

Postgraduate medicine, 1989

Related Questions

What is the role of HLA‑B27 testing in the diagnostic approach to axial spondyloarthritis?
In a 48-year-old HLA-B27-positive male who does not meet criteria for ankylosing spondylitis, presenting with chronic diffuse muscle pain, fatigue, dorsal spine pain, a normal spinal MRI (only prominent paraspinal muscles), and a family history of dry eye without dry mouth, what is the most likely diagnosis and what are the differential diagnoses?
In a 48-year-old man with chronic diffuse musculoskeletal pain, fatigue, dorsal spine discomfort, a normal spinal MRI, and a negative HLA‑B27 test, what is the most likely diagnosis and recommended initial management?
What is the clinical significance and management approach for patients with a correlation between positive Antinuclear Antibody (ANA) and Human Leukocyte Antigen B27 (HLA-B27)?
Which clinical findings are characteristic of spondyloarthritides: peripheral oligoarthritis, iridocyclitis (acute anterior uveitis), acute monoarthritis of the first metatarsophalangeal joint, mechanical-type low back pain, or Achilles tendinitis?
Which uterotonic medication should be given after dilation and curettage to promote uterine contraction and reduce bleeding?
What is the recommended next step in managing a 15‑year‑old with an active substance‑use disorder who is taking aripiprazole 2 mg daily and escitalopram 20 mg daily and presents with persistent mood destabilization, depression, and anxiety?
In an inpatient currently on aripiprazole 2 mg and escitalopram 20 mg with substance‑use disorder (including possible opioid use) and risk of suicidal ideation and mania, what is the recommended medication and treatment plan?
What is the effect of vitamin A on fetal development?
What are the criteria for prophylactic low‑molecular‑weight heparin (LMWH) (including indications, contraindications, dosing, and duration) in patients immobilized due to a tibial fracture?
How should chronic active Epstein-Barr virus (EBV) infection be tested?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.